Jason Amello

CADL

Jason Amello serves as Chief Financial Officer at Candel Therapeutics, Inc. (CADL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$10.0K

Total Sells

1 trades

$18.1K

Net Position

Net Seller

$8.1K

Companies Traded

CADL

Active Period

Dec 2022 – Nov 2023

2 total trades

Most Recent

Sell CADL

Nov 28, 2023 · $18.1K

Jason Amello's Insider Trading at Candel Therapeutics, Inc. (CADL)

Buys

1 · $10.0K

Sells

1 · $18.1K

Total Shares Bought

5,568

Total Shares Sold

20,153

CADL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 28, 2023	Sell	20,153	$0.90	$18.1K	0
Dec 8, 2022	Buy	5,568	$1.80	$10.0K	0

Related Insiders

Francesca Barone

officer: Chief Scientific Officer

CADLSell · Jul 1, 2026

Seshu Tyagarajan

officer: Chief Technology Officer

CADLSell · Jul 1, 2026

Paul B Manning

director

CADLBuy · Feb 26, 2026

William Garrett Nichols

Chief Medical Officer

CADLSell · Jul 28, 2025

Explore More Insider Trading Data

CADL Insider Trading Activity

View all insider trades at Candel Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity